Flow injection analysis quantifies multidrug resistance phenotype

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Understanding the relationship between DNA damage, drug resistance, and cell survival is crucial for cancer therapy.
• Leukemic cell lines, including adriamycin-resistant (P388/ADR), mitoxantrone-resistant (P388/MTN), and sensitive (P388/S) variants, are used to study drug responses.

Purpose of the Study:

• To investigate the relationship between DNA damage, drug resistance, and cell survival using flow injection analysis (FIA).
• To evaluate the efficacy of FIA in differentiating tumor cell responses to DNA-damaging agents.

Main Methods:

• Flow injection analysis (FIA) was utilized to measure DNA damage, repair, and drug accumulation in leukemic cells.
• Resistant and sensitive leukemic cell lines were exposed to varying concentrations of adriamycin.

Main Results:

• FIA successfully differentiated subtle differences in tumor response between sensitive and resistant cells.
• The method demonstrated high sensitivity, capable of measuring drug concentrations as low as 5 x 10(-11)M.
• FIA results for DNA strand-break and repair were comparable to other established methods.
• The technique also allowed for the assessment of cross-resistance and cross-sensitivity.

Conclusions:

• Flow injection analysis (FIA) is a rapid, sensitive, and reproducible technique for monitoring tumor cell responses to DNA-damaging agents.
• FIA provides valuable insights into the mechanisms of drug resistance and aids in personalized cancer treatment strategies.